vs
Side-by-side financial comparison of TREASURE GLOBAL INC (TGL) and Vir Biotechnology, Inc. (VIR). Click either name above to swap in a different company.
Vir Biotechnology, Inc. is the larger business by last-quarter revenue ($240.0K vs $182.5K, roughly 1.3× TREASURE GLOBAL INC). TREASURE GLOBAL INC runs the higher net margin — -1169.1% vs -67975.4%, a 66806.3% gap on every dollar of revenue. On growth, TREASURE GLOBAL INC posted the faster year-over-year revenue change (-12.0% vs -89.9%). TREASURE GLOBAL INC produced more free cash flow last quarter ($-2.4M vs $-167.9M). Over the past eight quarters, TREASURE GLOBAL INC's revenue compounded faster (-83.5% CAGR vs -88.0%).
Treasure Global Inc is a consumer technology company offering integrated digital commerce solutions, customer loyalty rewards programs, and cashless payment services. It primarily operates across Southeast Asian markets, serving individual users and small-to-medium enterprise clients.
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on developing innovative therapies and vaccines to address serious infectious diseases including COVID-19, hepatitis B, HIV, and influenza. It operates primarily in the global biopharmaceutical market, collaborating with leading industry partners to advance its pipeline of targeted immune-based solutions for patient populations worldwide.
TGL vs VIR — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $182.5K | $240.0K |
| Net Profit | $-2.1M | $-163.1M |
| Gross Margin | 0.7% | — |
| Operating Margin | -953.5% | -72267.9% |
| Net Margin | -1169.1% | -67975.4% |
| Revenue YoY | -12.0% | -89.9% |
| Net Profit YoY | -124.5% | 23.7% |
| EPS (diluted) | $-0.38 | $-1.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $182.5K | $240.0K | ||
| Q2 25 | $1.2M | $1.2M | ||
| Q1 25 | $666.5K | $3.0M | ||
| Q4 24 | $301.9K | $12.4M | ||
| Q3 24 | $207.4K | $2.4M | ||
| Q2 24 | $293.0K | $3.1M | ||
| Q1 24 | $1.6M | $56.4M | ||
| Q4 23 | $6.7M | $16.8M |
| Q3 25 | $-2.1M | $-163.1M | ||
| Q2 25 | — | $-111.0M | ||
| Q1 25 | $1.3M | $-121.0M | ||
| Q4 24 | $-232.3K | — | ||
| Q3 24 | $-950.7K | $-213.7M | ||
| Q2 24 | — | $-138.4M | ||
| Q1 24 | $-1.7M | $-65.3M | ||
| Q4 23 | $-1.2M | — |
| Q3 25 | 0.7% | — | ||
| Q2 25 | 68.2% | 99.1% | ||
| Q1 25 | 73.0% | — | ||
| Q4 24 | 74.2% | — | ||
| Q3 24 | 83.0% | 97.9% | ||
| Q2 24 | 31.0% | 98.3% | ||
| Q1 24 | 13.6% | 99.9% | ||
| Q4 23 | 5.1% | 95.2% |
| Q3 25 | -953.5% | -72267.9% | ||
| Q2 25 | — | -9754.3% | ||
| Q1 25 | -6.5% | -4602.5% | ||
| Q4 24 | -229.5% | — | ||
| Q3 24 | -391.4% | -9718.7% | ||
| Q2 24 | — | -5158.7% | ||
| Q1 24 | -85.9% | -142.0% | ||
| Q4 23 | -16.2% | — |
| Q3 25 | -1169.1% | -67975.4% | ||
| Q2 25 | — | -9139.9% | ||
| Q1 25 | 189.0% | -3989.6% | ||
| Q4 24 | -77.0% | — | ||
| Q3 24 | -458.5% | -8979.7% | ||
| Q2 24 | — | -4500.1% | ||
| Q1 24 | -107.3% | -115.8% | ||
| Q4 23 | -17.9% | — |
| Q3 25 | $-0.38 | $-1.17 | ||
| Q2 25 | — | $-0.80 | ||
| Q1 25 | $1.09 | $-0.88 | ||
| Q4 24 | $-11.32 | — | ||
| Q3 24 | $-17.62 | $-1.56 | ||
| Q2 24 | — | $-1.02 | ||
| Q1 24 | $-116.03 | $-0.48 | ||
| Q4 23 | $-2.22 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $497.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $12.0M | $796.1M |
| Total Assets | $16.6M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $497.8M | ||
| Q2 25 | — | $598.7M | ||
| Q1 25 | $2.5K | $790.9M | ||
| Q4 24 | $504.3K | $901.0M | ||
| Q3 24 | $44.1K | $909.0M | ||
| Q2 24 | $171.6K | $1.1B | ||
| Q1 24 | — | $1.1B | ||
| Q4 23 | — | $1.5B |
| Q3 25 | $12.0M | $796.1M | ||
| Q2 25 | $10.7M | $947.5M | ||
| Q1 25 | $29.1M | $1.0B | ||
| Q4 24 | $18.4M | $1.2B | ||
| Q3 24 | $6.3M | $1.2B | ||
| Q2 24 | $3.4M | $1.4B | ||
| Q1 24 | $3.1M | $1.5B | ||
| Q4 23 | $3.7M | $1.6B |
| Q3 25 | $16.6M | $1.0B | ||
| Q2 25 | $14.9M | $1.2B | ||
| Q1 25 | $30.4M | $1.3B | ||
| Q4 24 | $19.1M | $1.4B | ||
| Q3 24 | $7.1M | $1.5B | ||
| Q2 24 | $4.3M | $1.7B | ||
| Q1 24 | $4.2M | $1.8B | ||
| Q4 23 | $4.9M | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.8M | $-167.6M |
| Free Cash FlowOCF − Capex | $-2.4M | $-167.9M |
| FCF MarginFCF / Revenue | -1318.2% | -69952.9% |
| Capex IntensityCapex / Revenue | 353.3% | 132.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-824.0M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-1.8M | $-167.6M | ||
| Q2 25 | $-9.5M | $-120.2M | ||
| Q1 25 | $-4.2M | $-78.1M | ||
| Q4 24 | $-606.2K | $-446.4M | ||
| Q3 24 | $-976.3K | $-171.5M | ||
| Q2 24 | $-4.7M | $-77.8M | ||
| Q1 24 | $-1.1M | $-109.4M | ||
| Q4 23 | $-1.2M | $-778.8M |
| Q3 25 | $-2.4M | $-167.9M | ||
| Q2 25 | $-9.5M | $-122.8M | ||
| Q1 25 | $-4.2M | $-79.7M | ||
| Q4 24 | — | $-453.7M | ||
| Q3 24 | — | $-174.2M | ||
| Q2 24 | $-4.7M | $-78.5M | ||
| Q1 24 | $-1.1M | $-111.3M | ||
| Q4 23 | $-1.2M | $-800.4M |
| Q3 25 | -1318.2% | -69952.9% | ||
| Q2 25 | -822.4% | -10111.8% | ||
| Q1 25 | -635.6% | -2630.1% | ||
| Q4 24 | — | -3666.2% | ||
| Q3 24 | — | -7321.3% | ||
| Q2 24 | -1614.2% | -2553.3% | ||
| Q1 24 | -67.1% | -197.4% | ||
| Q4 23 | -17.9% | -4767.7% |
| Q3 25 | 353.3% | 132.1% | ||
| Q2 25 | 1.3% | 209.1% | ||
| Q1 25 | 0.3% | 53.7% | ||
| Q4 24 | — | 59.0% | ||
| Q3 24 | — | 116.3% | ||
| Q2 24 | 5.7% | 21.7% | ||
| Q1 24 | 0.0% | 3.3% | ||
| Q4 23 | 0.1% | 128.5% |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -3.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
